Thelansis

Tardive dyskinesia (TD) is an involuntary neurological movement disorder caused by the use of dopamine receptor blocking drugs prescribed to treat certain psychiatric or gastrointestinal conditions. Tardive dyskinesia is caused by the long-term use of a class of neuroleptics drugs. These drugs are also called antipsychotics or major tranquilizers. ·        The occurrence of Tardive dyskinesia (TD) is estimated to be 2%-5% annually, and the condition occurs in 15%-30% of those who receive long-term treatment with APDs.   Thelansis’s “Tardive Dyskinesia (TD) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Tardive Dyskinesia (TD) treatment modalities options for eight maj...

 Tardive dyskinesia (TD) is an involuntary neurological movement disorder caused by the use of dopamine receptor blocking drugs prescribed to treat certain psychiatric or gastrointestinal conditions. Tardive dyskinesia is caused by the long-term use of a class of neuroleptics drugs. These drugs are also called antipsychotics or major tranquilizers. ·        The occurrence of Tardive dyskinesia (TD) is estimated to be 2%-5% annually, and the condition occurs in 15%-30% of those who receive long-term treatment with APDs. Thelansis’s “Tardive Dyskinesia (TD) Market Outlook, Epidemiology , Competitive Landscape , and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Tardive Dyskinesia (TD) treatment modalities options for eigh...